Inclisiran Safe, Effective in Reducing LDL-C in Patients With Familial Hypercholesterolemia or ASCVD
Researchers conducted a patient-level pooled analysis from phase 3 trials of inclisiran in patients with familial hypercholesterolemia or ASCVD.
Researchers conducted a patient-level pooled analysis from phase 3 trials of inclisiran in patients with familial hypercholesterolemia or ASCVD.
Higher intake of unprocessed red meat, poultry not tied to increased risks for mortality, major cardiovascular disease.
And passage of antibodies through the placenta and breastmilk appears to confer immunity to newborns.
About 90% of those with familial hypercholesterolemia have not been diagnosed or treated for it, leaving them more vulnerable for COVID-19 infection and its complications.
Researchers studied whether hypertensive disorders of pregnancy (HDP), either gestational hypertension or pre-eclampsia, can be associated with increased risk of premature mortality.
Computed tomography angiography and invasive coronary angiography may equally predict clinical outcome in patients with nonST segment elevation ACS.
Bouts of intense exercise can lead to cardiorespiratory fitness and decreased risk for cardiovascular disease in patients with type 2 diabetes.
Telmisartan, an angiotensin II receptor blocker, is indicated for the treatment of hypertension.
Patients with type 1 and type 2 diabetes have a high risk of cardiovascular disease (CVD), but now, a new study shows that type 1 diabetes patients are more susceptible to both cardiovascular and renal disease.
Adults using low-dose aspirin for primary or secondary prevention of CVD had lower likelihood of COVID-19 infection vs nonusers.